Chennai Meenakshi Multispeciality Hospital Ltd vs Choksi Laboratories Ltd Stock Comparison
Chennai Meenakshi Multispeciality Hospital Ltd vs Choksi Laboratories Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Chennai Meenakshi Multispeciality Hospital Ltd is ₹ 36.4 as of 23 Oct 15:30
. The P/E Ratio of Chennai Meenakshi Multispeciality Hospital Ltd changed from 4.3 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Choksi Laboratories Ltd changed from 84.7 on March 2022 to 36.7 on March 2026 . This represents a CAGR of -15.40% over 5 years The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 7.28 crore on March 2021 to ₹ 24.66 crore on March 2026 . This represents a CAGR of 22.55% over 6 yearsThe Market Cap of Choksi Laboratories Ltd changed from ₹ 5.5 crore on March 2021 to ₹ 72.16 crore on March 2026 . This represents a CAGR of 53.58% over 6 years The revenue of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 8.7 crore as compare to the Mar '26 revenue of ₹ 10.05 crore. This represent the decline of -13.43% The revenue of Choksi Laboratories Ltd for the Jun '26 is ₹ 12.08 crore as compare to the Mar '26 revenue of ₹ 12.88 crore. This represent the decline of -6.21% The ebitda of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0.46 crore as compare to the Mar '26 ebitda of ₹ 0.48 crore. This represent the decline of -4.17% The ebitda of Choksi Laboratories Ltd for the Jun '26 is ₹ 3.3 crore as compare to the Mar '26 ebitda of ₹ 3.71 crore. This represent the decline of -11.05% The net profit of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ -0.38 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00%
The net profit of Choksi Laboratories Ltd changed from ₹ 0.42 crore to ₹ 0.58 crore over 9 quarters. This represents a CAGR of 15.43%
The Dividend Payout of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Choksi Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Chennai Meenakshi Multispeciality Hospital Ltd
Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, was incorporated in 1990.
The Company name was changed from Devaki Hospital Limited to Chennai Meenakshi Multispeciality Hospital Limited in October, 2007.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore.
The hospital has an infrastructure comprising of around 105 Beds including ICU Beds, Operating Theatre, a modern dialysis Unit besides a host of other facilities.
The Company has a pool of talented and experienced doctors who are further supported by a team of highly qualified and experienced and dedicated support staff and cutting edge technology.
The Company operate into various departments like Cardiology Department; Casualty Department; Diagnostic Services; Intensive Care Unit; Nephrology Department and Physiotherapy Department.
About Choksi Laboratories Ltd
Choksi Laboratories Limited, incorporated on 29 January, 1993 provides contract testing and analytical services.
CLL is a group of research laboratories and consulting offices, offering analysis, calibration, pollution control, research and consultancy services to a broad spectrum of industries.
The Company analyses, for its clients, or as a regulatory requirement pharmaceuticals, food and agricultural products, construction materials, chemicals, Calibration and environment Monitoring services.
The Company currently has facilities for analysis of over 1000 products and materials, with more being added every day.
It provides calibration of production & quality control equipment with traceability to national / international standards.
This means that the equipment are precise and therefore reducing the probability of end-product defects / rejects.
FAQs for the comparison of Chennai Meenakshi Multispeciality Hospital Ltd and Choksi Laboratories Ltd
Which company has a larger market capitalization, Chennai Meenakshi Multispeciality Hospital Ltd or Choksi Laboratories Ltd?
Market cap of Chennai Meenakshi Multispeciality Hospital Ltd is 27 Cr while Market cap of Choksi Laboratories Ltd is 144 Cr
What are the key factors driving the stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Choksi Laboratories Ltd?
The stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Choksi Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Chennai Meenakshi Multispeciality Hospital Ltd and Choksi Laboratories Ltd?
As of October 25, 2026, the Chennai Meenakshi Multispeciality Hospital Ltd stock price is INR ₹36.4. On the other hand, Choksi Laboratories Ltd stock price is INR ₹207.75.
How do dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Choksi Laboratories Ltd compare?
To compare the dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Choksi Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.